» Authors » Yasuhito Kobayashi

Yasuhito Kobayashi

Explore the profile of Yasuhito Kobayashi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 68
Citations 951
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugawara K, Sakashita S, Fukuda T, Murakami C, Oka D, Amori G, et al.
Ann Surg Oncol . 2024 Dec; 32(3):1963-1972. PMID: 39645554
Background: Little is known about the survival impacts of mitochondrial status in esophageal squamous cell carcinoma (ESCC) patients who undergo neoadjuvant chemotherapy (NAC) followed by surgery. Methods: In total, 260...
2.
Sugawara K, Fukuda T, Murakami C, Oka D, Yoshii T, Amori G, et al.
Cancer Sci . 2024 May; 115(8):2819-2830. PMID: 38693726
With the advent of immune checkpoint inhibitors (ICIs), a better understanding of tumor microenvironment (TME) is becoming crucial in managing esophageal squamous cell carcinoma (ESCC) patients. We investigated the survival...
3.
Kobayashi Y, Miyake Y, Ishiwari F, Ishiwata S, Saeki A
RSC Adv . 2023 May; 13(22):15107-15113. PMID: 37207099
The bulk heterojunction structures of organic photovoltaics (OPVs) have been overlooked in their machine learning (ML) approach despite their presumably significant impact on power conversion efficiency (PCE). In this study,...
4.
Morimoto Y, Ishiguro T, Uozumi R, Takano K, Kobayashi Y, Kobayashi Y, et al.
Intern Med . 2022 Apr; 61(7):979-988. PMID: 35370255
Objective Phosphate is a fundamental element involved in a number of physiological pathways. A previous study showed abnormal laboratory findings and a higher mortality in hypophosphatemic patients than in normophosphatemic...
5.
Ishiguro T, Kobayashi Y, Shimizu Y, Uemura Y, Isono T, Takano K, et al.
Intern Med . 2021 Sep; 60(23):3709-3719. PMID: 34544950
Objective Viral pneumonia is not rare in community-acquired pneumonia (CAP). Mixed or secondary pneumonia (coinfection) can be seen in viral pneumonia; however, its frequency in coronavirus disease 2019 (COVID-19) has...
6.
Tozuka K, Wongsirisin P, Nagai S, Kobayashi Y, Kanno M, Kubo K, et al.
Sci Rep . 2021 Jul; 11(1):14238. PMID: 34244560
To understand the mechanism underlying metastasis, identification of a mechanism-based and common biomarker for circulating tumour cells (CTCs) in heterogenous breast cancer is needed. SET, an endogenous inhibitor of protein...
7.
Ishiguro T, Takano K, Kagiyama N, Hosoda C, Kobayashi Y, Takaku Y, et al.
Respir Med Case Rep . 2020 Sep; 31:101207. PMID: 32874906
Objective: To clarify what future problems must be resolved and how clinical findings of SARS-CoV-2 infection differ from those of cHCoV infection. Methods: Patients and Methods Clinical characteristics of 14...
8.
Morimoto Y, Ishiguro T, Kasuga K, Takano K, Ozawa R, Isono T, et al.
Intern Med . 2020 Sep; 60(3):435-439. PMID: 32863361
Two patients, a 60-year-old man and 43-year-old woman, presented to our hospital with symptoms of respiratory tract infection. These patients showed imaging findings of multiple small nodules, ground-glass opacities, and...
9.
Shibata S, Ishiguro T, Kobayashi Y, Koike M, Numano T, Shimizu Y, et al.
Respir Med Case Rep . 2020 Aug; 31:101180. PMID: 32766111
We experienced a 72-year-old man who developed laboratory-confirmed human coronavirus HKU1 pneumonia. PCR testing for SARS-CoV-2 from a nasopharyngeal specimen was negative twice, and rapid immunochromatographic antibody test (RIAT) using...
10.
Mizumoto Y, Yokoyama S, Matsuda K, Iwamoto H, Mitani Y, Tamura K, et al.
Mol Clin Oncol . 2020 Jan; 12(2):126-133. PMID: 31929883
Adjuvant chemotherapy with capecitabine is frequently not completed due to adverse events, including hand-foot syndrome. A higher completion rate of capecitabine by reduction of the side effects may improve disease-free...